Algernon Pharmaceuticals (TSE:AGN) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Algernon Pharmaceuticals invites stakeholders to a special CEO interview and Q&A session with CEO Christopher J. Moreau, hosted by Market Radius Research on April 16th, 2024. The discussion will cover the recent Ifendprodil deal and future plans for the company’s DMT stroke research. Attendees can interact live or access the archived webcast later.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.
